Arab Health 2024 was the show where M Care publicly stopped being described as a generics exporter and started being introduced as an institutional-supply desk. The difference was one wall graphic, six category tiles, and about four weeks of arguments in Mumbai about which SKUs to foreground.
The wall that went up at Dubai World Trade Centre had the M Care mark at the centre, and six service tiles around it — Hospital Medicines, Unlicensed Medicine, Critical Care, Oncology & Anti-TB, Orphan / Rare Drugs, and Surgicals & Dentals. It was the first time buyers at the show could read the full positioning on one surface, and it changed the kind of conversations we had.
Why “Wholesaler”
We launched the 2024 booth under the Global Pharmaceuticals Wholesaler framing because that was the language the UK and GCC importer community still defaulted to. The tag described the function — bulk export, lot-level CoAs, MHRA / SFDA / DHA-aligned dossiers — without overclaiming on the regulatory chain. We'd retire the word a year later, but in 2024 it was the right shorthand.
The six tiles, and the buyers who asked about them
- Hospital medicines. The tile that drew the most foot traffic. GCC procurement teams were looking for a second-source for high-volume, low-margin formulary lines after a difficult 2023 for some of the Western European manufacturers.
- Unlicensed medicine. Named-patient, compassionate-use, and special-access pathways. The tile that drew the longest conversations, invariably with a hospital pharmacist rather than a procurement lead.
- Critical care. ICU and emergency-formulary lines — anaesthesia, pressors, paralytics, electrolytes. Heavily tender-driven, strongly documentation-sensitive.
- Oncology & anti-TB. Low volumes, high documentation, serious cold-chain. The tile the Mumbai regulatory desk spent the most hours on before the show.
- Orphan / rare drugs. A short list, by definition. The tile that always ended in an email exchange rather than a handshake — because the conversation requires the exact molecule name before it can be useful.
- Surgicals & dentals. A quieter tile at Arab Health, but one that paid off disproportionately on the African-importer side over the following year.
What we took away
Three lessons from Arab Health 2024 that we carried into the next two years of shows:
- The category wall works. Putting every institutional line on a single graphic compressed a ten-minute pitch into a ten-second scan. We kept the structure for 2025 and iterated on the labels.
- The documentation pack closes deals. The stands that converted best weren't the ones with the biggest prize giveaways — they were the ones with a printed documentation dossier ready to slide across the table.
- GS1 accreditation matters more than you think. Our GS1 accreditation badge was the second thing most buyers asked about after the product range. In 2025 we made it louder.
